Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

Summary

The goal of this clinical trial is to evaluate the protective efficacy of S. Flexneri-S. Sonnei bivalent conjugate vaccine against diarrhea caused by Shigella infection in infants and children aged 6 months to 5 years. Researchers will observe the incidence of diarrhea of any severity due to Shigella flexneri and Shigella sonnei infection 30 days after full immunization. The subjects will receive 2 doses of vaccination.

Timeline

Start

2025-05-12

Primary completion

2028-07-02

Completion

2028-07-30

Drugs

Indications